BJGMC-JHU Clinical Research Site (CRS) in Pune hosted 400+ engaging panel discussions, interactive outreach programs, and impactful awareness campaigns for World TB Day 2024.
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune. “Evidence from this study will give insights into the adoption of...
